SCHEMBL4729677

SCHEMBL4729677

CCOC(=O)C(=O)C1COC(=O)c2ccc(OC)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 1/20 0.41
PPARG P37231 5/20 0.41
BRD4 O60885 2/20 0.40
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
TP53 P04637 2/20 0.39
MAPT P10636 2/20 0.39
CYP19A1 P11511 1/20 0.39
ATM Q13315 1/20 0.39
ALDH1A1 P00352 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ALOX15 P16050 2/20 0.38
CYP3A4 P08684 2/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4726333 0.85 ALDH1A1 (0.38) MAPTALDH1A1KDM4EMEN1HPGD
SCHEMBL4728954 0.85 TDP2 (0.45) MAPTALDH1A1NPSR1MEN1KMT2A
SCHEMBL4729605 0.85 MAPK1 (0.41) TP53MAPTALDH1A1KDM4EUSP2
SCHEMBL4728618 0.83 ALDH1A1 (0.48) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL4727256 0.82 CYP19A1 (0.50) PPARGMTNR1ATP53MAPTCYP19A1
SCHEMBL17978220 0.79 CYP19A1 (0.51) MTNR1ATP53MAPTCYP19A1ALDH1A1
SCHEMBL4784489 0.76 CYP1A1 (0.41) CYP1A1PPARGBRD4MAPTATM
SCHEMBL19128297 0.73 CYP24A1 (0.51) PPARGMAPTCYP19A1ALDH1A1KDM4E
SCHEMBL24188767 0.72 KDM4E (0.43) PPARGBRD4MAPTALDH1A1KDM4E
SCHEMBL12890 0.72 L3MBTL1 (0.45) PPARGBRD4MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008035356-A2 NOVEL CANNABINOID RECEPTOR LIGANDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LIMITED (IN) 2008-03-27 WO claimed